Optimization of the Conditions of Analysis of Exhaled Air by Gas Chromatography–Mass Spectrometry for the Noninvasive Diagnostics of Lung Cancer


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We optimized procedures for the collection, preparation, and storage of samples of exhaled air and the conditions for determining volatile organic compounds in exhaled air by gas chromatography–mass spectrometry (GC–MS), the presence or change in the concentration of which can be caused by lung cancer. The analysis circuit includes group adsorption preconcentration followed by the thermal desorption and determination of analytes by GC–MS. Polymer bags of a Tedlar® film were used for sample collection. The conditions and periods of the storage of samples in bags and adsorption tubes are determined. A method for cleaning and conditioning bags is proposed. For preconcentrating exhaled air components, we used hydrophobic adsorbents (Porapak™ P, Porapak™ Q, and Tenax® TA) and three-section tubes containing Tenax® GR, Carbopack™ B, and Carbosieve® S-III. Their relative efficiency was evaluated by assessing the residual background of gas emission from the adsorbent, the magnitude of the analytical signal, the efficiency of adsorption/desorption, and the efficiency of storage. The conditions for the preconcentration of volatile organic compounds (volume and rate of aspiration, time, and temperature of thermal desorption) are optimized. The main volatile organic compounds in the exhaled air of conditionally healthy volunteers were identified, and their concentrations are evaluated.

About the authors

I. S. Gorbunov

Institute of Chemistry, St. Petersburg State University

Author for correspondence.
Email: i.s.gorbunov@spbu.ru
Russian Federation, St. Petersburg, 198504

A. R. Gubal’

Institute of Chemistry, St. Petersburg State University

Email: i.s.gorbunov@spbu.ru
Russian Federation, St. Petersburg, 198504

A. A. Ganeev

Institute of Chemistry, St. Petersburg State University; Institute of Toxicology, Federal Medical-Biological Agency

Email: i.s.gorbunov@spbu.ru
Russian Federation, St. Petersburg, 198504; St. Petersburg, 192019

O. V. Rodinkov

Institute of Chemistry, St. Petersburg State University

Email: i.s.gorbunov@spbu.ru
Russian Federation, St. Petersburg, 198504

L. A. Kartsova

Institute of Chemistry, St. Petersburg State University

Email: i.s.gorbunov@spbu.ru
Russian Federation, St. Petersburg, 198504

E. A. Bessonova

Institute of Chemistry, St. Petersburg State University

Email: i.s.gorbunov@spbu.ru
Russian Federation, St. Petersburg, 198504

A. I. Arsen’ev

Petrov National Oncology Medical Research Center, Ministry of Health of the Russian Federation

Email: i.s.gorbunov@spbu.ru
Russian Federation, St. Petersburg, 197758

A. O. Nefedov

Petrov National Oncology Medical Research Center, Ministry of Health of the Russian Federation

Email: i.s.gorbunov@spbu.ru
Russian Federation, St. Petersburg, 197758

L. A. Kraeva

Pasteur Research Institute of Epidemiology and Microbiology

Email: i.s.gorbunov@spbu.ru
Russian Federation, St. Petersburg, 197101


Copyright (c) 2019 Pleiades Publishing, Inc.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies